Nizar Serhan

Nizar Serhan is a seasoned researcher specializing in preclinical in vivo pharmacology, currently serving as Team Leader and Research Scientist at Evotec since January 2020, where responsibilities include project management, study design, and team supervision. Prior to this role, Nizar held post-doctoral research positions at Inserm from December 2017 to December 2019, focusing on the targeting of pancreatic cancer cells using magnetic nanoparticles and HSP70 inhibitors, and from July 2013 to July 2017, investigating the anticancer effects of Oxysterol and Dendrogenin A on acute myeloid leukemia. Nizar began the academic journey as a Ph.D. student at Inserm from September 2009 to March 2013, studying the role of the P2Y13 receptor in cholesterol transport and its implications for atherosclerosis. Academic qualifications include a Ph.D. in Cardiovascular Physiopathology from Université Paul Sabatier Toulouse III and a Master's degree in Human Nutrition from Université Bordeaux.